News & Media
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Category Defining Molecular Diagnostics Company BillionToOne Further Solidifies its Long-Term Position by Securing $140 Million Non-Dilutive Financing with Oberland Capital
Category Defining Molecular Diagnostics Company BillionToOne Further Solidifies its Long-Term Position by Securing $140 Million Non-Dilutive Financing with Oberland Capital
BillionToOne Announces Green Journal Publication that Underscores the Role of cell-free DNA NIPT for Fetal Red Blood Cell Antigen Genotyping
BillionToOne Announces Green Journal Publication that Underscores the Role of cell-free DNA NIPT for Fetal Red Blood Cell Antigen Genotyping
Axios-BillionToOne raises $130M at $1B-plus valuation
Axios-BillionToOne raises $130M at $1B-plus valuation
Genomeweb-BillionToOne Raises $130M in Series D Financing Round
Genomeweb-BillionToOne Raises $130M in Series D Financing Round
Slice of Healthcare-BillionToOne Raises $130M In Series D Funding Round
Slice of Healthcare-BillionToOne Raises $130M In Series D Funding Round
Leading Molecular Diagnostics Company BillionToOne Raises $130 Million in Oversubscribed Series D Funding Over $1B+ Valuation
Leading Molecular Diagnostics Company BillionToOne Raises $130 Million in Oversubscribed Series D Funding Over $1B+ Valuation
Social Posts